TrialEBioMedicine2026

Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.

Tobias Bittner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.